ghk-cu tolerance desensitization downregulation antibody formation The role of glycosylation in autoimmune and alloimmune kidney diseases GHK-Cu Peptide: Clinical Evidence &
Description
This is where it is important to be clear
Pharmacokinetic endpoints: if the research objective includes PK characterisation, build in LC-MS quantification of serum peptide at multiple timepoints to generate a concentration-time curve
Background on the FYXWF insulin-mimetic motif: Schffer L et al
10.1210/en.2015-1726 76 HauschkaP
Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice
